Investor's Business Daily on MSN
Abbott Laboratories slammed on its post-Exact Sciences guidance
Abbott stock took a hit early Thursday on lackluster guidance for the year and second quarter following the takeover of Exact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results